We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Carlisle Companies
CSL
$14.9B
| $6.88M | 0.03% |
26,800
-69,606
| -72% | -$15.4M |
|
|
EFOR
577
Everforth Inc
EFOR
$1.37B
| $6.87M | 0.03% |
90,805
+15,496
| +21% | +$1.11M |
|
578
ESAB
ESAB
$5.29B
| $6.86M | 0.03% |
103,164
-24,238
| -19% | -$1.47M |
|
|
PR
579
Permian Resources
PR
$17.7B
| $6.86M | 0.03% |
626,229
-16,004
| -2% | -$164K |
|
580
Ryan Specialty Holdings
RYAN
$11B
| $6.83M | 0.03% |
152,209
-20,268
| -12% | -$853K |
|
581
Bunge Global
BG
$21.7B
| $6.7M | 0.03% |
+71,042
| New | +$6.59M |
|
582
Insight Enterprises
NSIT
$4.6B
| $6.68M | 0.03% |
45,646
-23,569
| -34% | -$3.16M |
|
583
StoneCo
STNE
$2.49B
| $6.56M | 0.03% |
514,666
-173,065
| -25% | -$2.16M |
|
584
Pebblebrook Hotel Trust
PEB
$2.05B
| $6.54M | 0.03% |
469,155
-346,657
| -42% | -$4.84M |
|
585
Tidewater
TDW
$4.55B
| $6.53M | 0.03% |
117,821
-120,546
| -51% | -$5.52M |
|
|
WCN
586
Waste Connections
WCN
$41.6B
| $6.53M | 0.03% |
45,677
-26,332
| -37% | -$3.67M |
|
587
Academy Sports + Outdoors
ASO
$3.03B
| $6.49M | 0.03% |
120,070
-249,984
| -68% | -$14.4M |
|
588
Barclays
BCS
$94.6B
| $6.4M | 0.03% |
814,831
-21,947
| -3% | -$170K |
|
589
dLocal
DLO
$4.34B
| $6.4M | 0.03% |
524,202
+132,678
| +34% | +$1.75M |
|
|
IAS
590
DELISTED
Integral Ad Science
IAS
| $6.39M | 0.03% |
+355,196
| New | +$6M |
|
|
EXE
591
Expand Energy Corp
EXE
$21.9B
| $6.36M | 0.03% |
76,024
-573,039
| -88% | -$45.7M |
|
592
Medifast
MED
$128M
| $6.34M | 0.03% |
68,776
-4,069
| -6% | -$362K |
|
593
Sun Life Financial
SLF
$44.8B
| $6.34M | 0.03% |
121,592
-89,526
| -42% | -$4.4M |
|
594
CVR Energy
CVI
$3.58B
| $6.32M | 0.03% |
211,062
+189,924
| +898% | +$5.11M |
|
595
Newell Brands
NWL
$2.63B
| $6.3M | 0.03% |
+724,393
| New | +$7.2M |
|
596
Park Hotels & Resorts
PK
$3.03B
| $6.28M | 0.03% |
489,835
-425,761
| -47% | -$5.43M |
|
597
Eli Lilly
LLY
$1.08T
| $6.23M | 0.03% |
13,284
-105,755
| -89% | -$44.4M |
|
|
SKX
598
DELISTED
Skechers
SKX
| $6.23M | 0.03% |
+118,282
| New | +$6.05M |
|
599
Jack Henry & Associates
JKHY
$11.1B
| $6.21M | 0.03% |
37,091
+14,678
| +65% | +$2.28M |
|
600
Bank of Hawaii
BOH
$3.15B
| $6.2M | 0.03% |
150,302
+56,440
| +60% | +$2.5M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.